survRM2adapt

MaRDI QIDQ61030CRANFDO

Authors Miki Horiguchi, Hajime Uno, Lu Tian

Last update 28 March 2023

Copyright license GNU General Public License, version 2.0

Software version identifier 1.1.0

Cites work

• A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time-to-event data in randomized clinical trials
• On assessing survival benefit of immunotherapy using long‐term restricted mean survival time

This page was built for software: survRM2adapt